StreetAlpha.app
Home › Stocks › GDRX

GoodRx Holdings, Inc. (GDRX)

Healthcare
$3.47
▼ −1.14%
LAST CLOSE · NOV 17

GoodRx operates a digital platform that lets consumers compare and save on prescription medication prices. It last closed at $3.47 on Nov 17, down 1.14% on the day.

AI Auto Pilots
Is GDRX in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$785.2M
−1.8% vs a year ago
Net income
$16.2M
−53.0% vs a year ago
EPS (diluted)
$0.06
−33.3% vs a year ago
Free cash flow
$197.1M
25.1% margin
Balance sheet
Cash & equivalents
$296.1M
At Jun 30
Debt
$486.6M
At Jun 30
Shareholder equity
$647.6M
Buybacks
$85.0M
Last 12 months
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $745.4M$745.4MFY2021FY2022: $766.6M$766.6MFY2022FY2023: $750.3M$750.3MFY2023FY2024: $792.3M$792.3MFY2024FY2025: $796.9M$796.9MFY2025

From GDRX's SEC filings, latest 10-Q for the period ending Jun 30, 2026 (filed Aug 5). Last 12 months adds up the four latest quarters.

Next report
—
No date on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
1 Sell
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Sell
1firm
0 Buy0 Hold1 Sell
Only 1 firm rated GDRX in the past 90 days, not enough for a consensus
Average 12-month target
$4.00
▲ 15.3% upside

Based on 1 analyst who set a price target on GDRX in the past 90 days. The average target is $4.00, with a high of $4.00 and a low of $4.00, compared with the last close of $3.47.

Low $4.00Avg $4.00High $4.00
Blue marker: last close $3.47
Highest target$4.00
Average target$4.00
Lowest target$4.00
Latest rating changes
BarclaysMaintained
Aug 21Sell$4
UBSMaintained
Aug 13Hold$3.75
CitigroupMaintained
Aug 11Buy$5
TD CowenMaintained
Aug 11Buy$5
Wells FargoMaintained
Aug 7Buy$5
DateFirmActionRatingPrice target
Aug 21BarclaysMaintainedSell$4
Aug 13UBSMaintainedHold$3.75
Aug 11CitigroupMaintainedBuy$5
Aug 11TD CowenMaintainedBuy$5
Aug 7Wells FargoMaintainedBuy$5
Loading…

Technical Analysis

GDRX · as of the Nov 17 close · updated after every close
Moving sideways

The stock sits between its 20 and 50 day averages. It is 17% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 48). The nearest support is the swing low (Sep 1) at $3.45, and the nearest resistance the Pivot at $3.49.

Short trendNeutral
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 4.4%/day
Key levels
$3.8952 week high+12.1%
$3.57Pivot R1+2.9%
$3.5520 day average+2.3%
$3.55Swing high (Oct 13)+2.3%
$3.49Pivot+0.6%
$3.47Last close
$3.45Swing low (Sep 1)−0.6%
$3.4450 day average−0.9%
$3.39Pivot S1−2.3%
$3.37100 day average−2.9%
$2.88200 day average−17.0%
$1.7752 week low−49.0%
Indicators
RSI (14)48.16Middle of its rangeNeutral
MACD0.02Below its signal lineBearish
Stochastic39.4Middle of its rangeNeutral
ADX (14)17.1No clear trend
Williams %R-69.9Oversold below −80, overbought above −20Neutral
CCI (20)-100.2Oversold below −100, overbought above 100Oversold
Rate of change−0.6%Change over 10 sessionsBearish
ATR (14)$0.15Typical daily range, 4.4% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for GDRX

What happened before

See how GDRX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow GDRX usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How GDRX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in GDRX in the last 90 days.

Loading…

See today’s whale options flow across the market →

GDRX Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●73 buying vs 79 selling
  • ●Shares held by funds +0.5%
  • ▲Funds holding +18
  • ●Superinvestors: 2 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding181163+11.0%
In funds' top 1034−25.0%
Held by funds–––
New / increased34 / 3915 / 50+12.3%
Reduced / sold out64 / 1551 / 27+1.3%
Put/call ratio2.014.23−52.4%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See GDRX institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether GDRX is in one of them and how their past GDRX trades turned out.

GDRX in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered GDRX in an article yet. Here's the latest on the wider market.

GDRX Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed Apr 23
Who traded GDRX · since 2021
Latest 1 filing
$100K – $250KTraded Mar 25, 2021Filed Apr 23, 2021
PersonTypeAmountTradedFiledDelay
Anthony E. GonzalezRBuy$100K – $250KMar 25, 2021Apr 23, 202129 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About GoodRx Holdings

GoodRx is a digital healthcare platform based in Santa Monica, California, that helps Americans find and pay less for prescription medications. Consumers can compare prescription prices across pharmacies and use discount codes for free, or pay a subscription for lower prices and added services such as telehealth visits and mail delivery. The company also offers tools for healthcare providers and sells advertising and affordability programs to pharma manufacturers. Its customers include consumers, physicians, pharmacy benefit managers, pharmacies and drug makers.

Headquarters
Santa Monica, CA